SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 124 filers reported holding SYNDAX PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $95,048 | -16.5% | 6,546 | +20.3% | 0.00% | 0.0% |
Q2 2023 | $113,880 | +11.6% | 5,441 | +12.6% | 0.00% | 0.0% |
Q1 2023 | $102,052 | -1.8% | 4,832 | +23.1% | 0.00% | 0.0% |
Q4 2022 | $103,895 | +10.5% | 3,925 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $94,000 | +40.3% | 3,925 | +11.3% | 0.00% | +33.3% |
Q2 2022 | $67,000 | +9.8% | 3,525 | 0.0% | 0.00% | +50.0% |
Q1 2022 | $61,000 | -20.8% | 3,525 | 0.0% | 0.00% | -33.3% |
Q4 2021 | $77,000 | +14.9% | 3,525 | 0.0% | 0.00% | +50.0% |
Q3 2021 | $67,000 | +9.8% | 3,525 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $61,000 | +15.1% | 3,525 | +48.1% | 0.00% | 0.0% |
Q1 2021 | $53,000 | 0.0% | 2,380 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $53,000 | +51.4% | 2,380 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $35,000 | 0.0% | 2,380 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $35,000 | +75.0% | 2,380 | +32.1% | 0.00% | +100.0% |
Q1 2020 | $20,000 | +122.2% | 1,801 | +80.1% | 0.00% | – |
Q4 2019 | $9,000 | +28.6% | 1,000 | 0.0% | 0.00% | – |
Q3 2019 | $7,000 | -22.2% | 1,000 | 0.0% | 0.00% | – |
Q2 2019 | $9,000 | +80.0% | 1,000 | 0.0% | 0.00% | – |
Q1 2019 | $5,000 | +25.0% | 1,000 | 0.0% | 0.00% | – |
Q4 2018 | $4,000 | -50.0% | 1,000 | 0.0% | 0.00% | – |
Q3 2018 | $8,000 | +14.3% | 1,000 | 0.0% | 0.00% | – |
Q2 2018 | $7,000 | -50.0% | 1,000 | 0.0% | 0.00% | -100.0% |
Q1 2018 | $14,000 | +366.7% | 1,000 | +172.5% | 0.00% | – |
Q4 2017 | $3,000 | -25.0% | 367 | 0.0% | 0.00% | – |
Q3 2017 | $4,000 | -20.0% | 367 | 0.0% | 0.00% | – |
Q2 2017 | $5,000 | 0.0% | 367 | 0.0% | 0.00% | – |
Q1 2017 | $5,000 | – | 367 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 1,025,000 | $24,631,000 | 16.36% |
Kynam Capital Management, LP | 2,272,915 | $54,618,000 | 11.51% |
Frazier Life Sciences Management, L.P. | 3,412,838 | $82,010,000 | 6.32% |
Foresite Capital Management IV, LLC | 690,000 | $16,581,000 | 5.33% |
Paradigm Biocapital Advisors LP | 1,085,142 | $26,076,000 | 3.48% |
ACUTA CAPITAL PARTNERS, LLC | 324,614 | $7,800,000 | 3.36% |
COMMODORE CAPITAL LP | 738,110 | $17,737,000 | 2.85% |
SPHERA FUNDS MANAGEMENT LTD. | 822,696 | $19,769,000 | 2.74% |
Avidity Partners Management LP | 5,586,900 | $134,253,000 | 2.73% |
HealthCor Management, L.P. | 859,240 | $20,648,000 | 2.58% |